ReviewFrontiers in clinical diabetes and healthcare2023

The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives.

Joaquim Barreto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.